In 2023, the observed mortality rate for tuberculosis in the US was 100 female deaths per hundred women. Forecasted data for 2024 to 2028 indicates a constant rate of 100 female deaths per hundred women. This suggests a steady situation with no significant year-on-year changes over this period. Due to this constancy, the compound annual growth rate (CAGR) is zero, reflecting no growth or decline in mortality rates from 2024 through 2028.

Future trends to monitor include:

Potential medical advancements or vaccines that could influence the TB mortality rate.
Changes in public health policies or funding for TB prevention and treatment.
Societal factors like improvements in living standards and healthcare accessibility.